Maharashtra Antibiotic And Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.24 Cr
- Company Age 45 Year, 3 Months
- Open Charges ₹ 2.90 Cr
About Maharashtra Antibiotic And Pharmaceutical
Maharashtra Antibiotic And Pharmaceutical Limited (MAAPL) is a Public Limited Union Government Company incorporated in India on 16 November 1979 and has a history of 45 years and three months. Its registered office is in Nagpur, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.24 Cr.
The company currently has active open charges totaling ₹2.90 Cr.
Company Details
- Location Nagpur, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1979GOI021904
- Company No.
021904
- Company Classification
Public Limited Union Government Company
- Incorporation Date
16 Nov 1979
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Maharashtra Antibiotic And Pharmaceutical?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Maharashtra Antibiotic And Pharmaceutical.
Enhance accessibility to Maharashtra Antibiotic And Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maharashtra Antibiotic And Pharmaceutical?
Unlock access to Maharashtra Antibiotic And Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.90 Cr
₹0
Charges Breakdown by Lending Institutions
- Sicom Limited : 2.00 Cr
- Industriel Development Bank Of India : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 1999 | Sicom Limited | ₹2.00 Cr | Open |
| 14 May 1981 | Industriel Development Bank Of India | ₹7.65 M | Open |
| 10 Oct 1980 | Industriel Development Bank Of India | ₹1.30 M | Open |
How Many Employees Work at Maharashtra Antibiotic And Pharmaceutical?
Unlock and access historical data on people associated with Maharashtra Antibiotic And Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maharashtra Antibiotic And Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharashtra Antibiotic And Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.